CLINICAL_TRIALS
trial_result
· 2016-11-18
Clinical Trial Update: Rituximab in Progressive Immunoglobulin A (IgA) Nephropathy [Phase 4]
Summary
Phase 4 study evaluating rituximab in progressive IgA nephropathy completed; results were posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mayo Clinic | Conditions: IgA Nephropathy | Phase 4 | Status: COMPLETED | Results posted: 2016-11-18